Results 331 to 340 of about 1,044,846 (392)
Platelet Factor 3 Activity in Washed Platelets [PDF]
Thrombosis and Haemostasis, 1973 SummaryPlatelets collected with an EDTA solution and simply washed in an incomplete Tyrode’s presented clotting times in the recalcification (man and rat) and the Stypven (rat) tests that were practically identical to those of the PRP when slow speed centrifugation was used (800 G in man, 1000 G in rat). This was demonstrated, in 6 pools of 5 rats each
S Renaud, P. Gautheron, H Rosenstein
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Platelet-Activating Factor and Platelet-Activating Factor Antagonists in Acute Pancreatitis
Digestive Surgery, 1999<i>Introduction:</i> Acute pancreatitis causes platelet-activating factor (PAF) to be released which induces systemic effects that contribute to circulatory disturbances and multiple organ failure. PAF has also been implicated as a key mediator in the progression of severe acute pancreatitis, which can lead to complications and unacceptably
openaire +2 more sources
Platelet-activating factor and the kidney
American Journal of Physiology-Renal Physiology, 1986Platelet-activating factor (PAF) represents a group of phospholipids with the basic structure of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine. A number of different cells are capable of producing PAF in response to various stimuli. The initial step of PAF formation is activation of phospholipase A2 in a calcium-dependent manner, yielding lyso-PAF ...
R. Neuwirth, D. Schlondorff
openaire +2 more sources
2000
Research leading to the discovery of platelet-activating factor (PAF) came from studying a reaction that triggered platelets to release histamine. It was attributed to a factor actively released from leukocytes. Platelet-activating factor was first identified by Benveniste et al. in 1972.1 Later it was recognized that this phospholipid mediator is also
W. A. Buurman +3 more
openaire +2 more sources
Research leading to the discovery of platelet-activating factor (PAF) came from studying a reaction that triggered platelets to release histamine. It was attributed to a factor actively released from leukocytes. Platelet-activating factor was first identified by Benveniste et al. in 1972.1 Later it was recognized that this phospholipid mediator is also
W. A. Buurman +3 more
openaire +2 more sources
Platelet-Activating Factor Antagonists
Annual Review of Pharmacology and Toxicology, 1987Over the past decade platelet-activating factor has achieved the status of an important inflammatory mediator. The scientific enthusiasm and number of research investigators, publications, and meetings recently devoted to PAF suggest that this mediator will be the subject of continued study in the foreseeable future.
R N Saunders, D A Handley
openaire +3 more sources
Nonimmunological production of leukotrienes induced by platelet-activating factor.
Science, 1982Platelet-activating factor caused rapid pulmonary vasoconstriction and edema in isolated lungs perfused with albumin-free salt solution devoid of formed blood elements.
N. Voelkel +4 more
semanticscholar +1 more source
Platelet Activating Factor and Conception
American Journal of Reproductive Immunology, 1996PURPOSE: This review provides evidence for the involvement of platelet activating factor (PAF) in the several facets of pregnancy establishment.METHODS: A comprehensive literature review and new data.RESULTS: PAF has a role in spermatozoal function, fertilization, embryo development, and implantation.CONCLUSIONS: PAF is intimately involved in ...
N. Gleicher +5 more
openaire +3 more sources
Association of platelet-activating factor with primary acquired cold urticaria.
New England Journal of Medicine, 1985We investigated the possibility that the inflammatory reaction in primary acquired cold urticaria might be associated with the release of platelet-activating factor.
K. E. Grandel +4 more
semanticscholar +1 more source
Revue Française d'Allergologie et d'Immunologie Clinique, 1977
Resume Il existe dans les basophiles et les mastocytes de nombreuses especes de mammiferes un facteur agregeant les plaquettes qui represente par consequent un lien entre la pathologie liee a la degranulation des basophiles/mastocytes, c'est-a-dire l'hypersensibilite immediate, et les plaquettes sanguines.
openaire +2 more sources
Resume Il existe dans les basophiles et les mastocytes de nombreuses especes de mammiferes un facteur agregeant les plaquettes qui represente par consequent un lien entre la pathologie liee a la degranulation des basophiles/mastocytes, c'est-a-dire l'hypersensibilite immediate, et les plaquettes sanguines.
openaire +2 more sources
Seminal Platelet-Activating Factor
Seminars in Thrombosis and Hemostasis, 2007Platelet-activating factor (PAF; 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphorylcholine) is a potent signaling phospholipid with pleiotropic biologic activities. Since its discovery more than 30 years ago, numerous investigators have documented its presence in a variety of tissues.
openaire +3 more sources